Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Infectious mononucleosis

J Peter1, C G Ray

  • 1Department of Pediatrics, St. Louis University School of Medicine and Cardinal Glennon Children's Hospital, MO., USA.

Pediatrics in Review
|August 26, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Analysis of adverse events following COVID-19 vaccination and infection: A retrospective, comparative cohort study using a claims database from Discovery Health, a managed care organisation in South Africa.

South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde·2026
Same author

Urticaria and Angioedema: When East Meets West-and the Middle.

Allergy·2026
Same author

The International Guideline for the Definition, Classification, Diagnosis and Management of Urticaria.

Allergy·2026
Same author

Icatibant Use During Pregnancy: A South African Case Series.

Journal of investigational allergology & clinical immunology·2025
Same author

Successful rechallenge of rifabutin in rifampicin-induced thrombocytopenia during TB treatment.

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2025
Same author

Spectrum of offending drugs and cutaneous adverse drug reactions requiring hospitalisation in a tertiary South African hospital in TB/HIV endemic setting.

Frontiers in allergy·2024
Same journal

Hemangiomas: Beyond the Skin.

Pediatrics in review·2026
Same journal

More Than Innocent: A Continuous Murmur in an Infant.

Pediatrics in review·2026
Same journal

Genetic Testing.

Pediatrics in review·2026
Same journal

Visual Diagnosis: Term Infant With a Hemorrhagic Dermatologic Lesion.

Pediatrics in review·2026
Same journal

Long-Term Complications of Sickle Cell Disease.

Pediatrics in review·2026
Same journal

Pediatric Multisystemic Illness With Cardiac Involvement: A Diagnostic Challenge.

Pediatrics in review·2026
See all related articles

Epstein-Barr virus (EBV)-induced infectious mononucleosis (IM) is typically self-limiting. Current management focuses on supportive care, with limited evidence for antiviral use in immunocompetent individuals.

Area of Science:

  • Infectious Diseases
  • Virology
  • Immunology

Background:

  • Infectious mononucleosis (IM) is commonly caused by Epstein-Barr virus (EBV).
  • The infection typically presents with fever, pharyngitis, and adenopathy.
  • Management strategies for EBV-induced IM require clear definition.

Purpose of the Study:

  • To summarize the clinical presentation and management of EBV-induced infectious mononucleosis.
  • To review the current evidence regarding treatment options, including supportive care, corticosteroids, and antiviral agents.
  • To highlight potential complications and their rarity.

Main Methods:

  • Literature review of studies on EBV-induced IM.
  • Analysis of clinical guidelines and case reports.

Related Experiment Videos

  • Synthesis of evidence on management and treatment efficacy.

    • Main Results:

    • EBV-induced IM is generally self-limiting, with characteristic symptoms.
    • Supportive care is the mainstay of management.
    • Streptococcal pharyngitis requires specific treatment when co-occurring.
    • Corticosteroids are indicated for significant upper airway obstruction.
    • Antiviral agents lack substantial evidence for immunocompetent patients.

    Conclusions:

    • EBV-induced IM management primarily involves supportive measures.
    • Specific treatments are reserved for complications or co-infections.
    • Antiviral therapy is not routinely recommended for immunocompetent individuals.
    • While rare, life-threatening complications can occur.